期刊文献+

糖原累积病Ⅱ型七例的临床表现及基因突变分析 被引量:8

Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type II
原文传递
导出
摘要 目的 报道7例糖原累积病Ⅱ型(GSDⅡ)的临床表现及α-1,4葡萄糖苷酶(GAA)基因突变特点.方法 2003-2011年在北京大学第一医院行肌肉活检的患者中有7例诊断为GSDⅡ.其中婴儿型1例,其主要症状为生后出现全身力弱、心脏扩大、呼吸困难和肝脏肿大;晚发型患者6例,发病年龄在1~29岁,主要表现为进展性肢体力弱,其中2例有呼吸肌受累.7例患者均伴随CK升高,5例肌电图呈肌源性损害,1例为神经源性损害.肌肉活检均发现肌纤维存在嗜碱性空泡,电镜检查发现大量膜性包裹的糖原.应用PCR产物直接测序法对患者进行GAA基因的所有外显子及其侧翼序列突变检测.对发现的新突变位点在100例正常对照中进行筛查.结果 7例GSDⅡ患者均存在GAA基因突变,共检测出11种点突变和1种缺失突变,其中p.P361L、p.P266S、p.R437C、p.R600C、p.W746S和p.W746*为文献已经报道的突变,p.R168Q、p.R168P、p.E521V、p.R594H和c.827_845del为尚未报道的新突变类型.除p.R168Q在2例正常对照中检测到外,其余新突变均未发现正常携带者.7例GSDⅡ患者携带的突变各不相同,仅p.P361L和p.W746 *出现在两例患者中.结论 我国GSDⅡ患者存在较多新发突变,提示该病可能具有较多个体化突变.p.P266S、p.P361L和p.R437C突变可能与临床晚发型的GSDⅡ有一定相关性. Objective To explore the clinical features and acid alpha-glucosidase (GAA) gene mutations of Chinese patients with glycogen storage disease type Ⅱ (GSD Ⅱ).Methods Seven patients with GSD Ⅱ were diagnosed by muscle pathology examination at Department of Neurology,Peking University First Hospital from 2003 to 2011.One patient with infant-onset presented development retardation,generalized muscle weakness,dyspnea,cardiomegaly and hepatomegaly.Six cases were of late-onset ranging from 1 to 29 years.Their main clinical features included progressive muscle weakness.Two patients developed respiratory insufficiency.Increased serum creatine kinase was detected in all of them.Electromyography studies showed myopathic (n =5) and neuropathic (n =1) changes.Muscle biopsies showed basophilic vacuoles in muscle fibers containing a large amountsof glycogen on electron microscopy.GAA gene mutation was detected by direct sequencing of polymerase chain reaction (PCR) product.Novel mutations were screened in 100 normal controls.Results GAA gene mutations were found in all of them,including 10 point mutations and 1 frameshift deletion.Six mutations (p.P361 L,p.P266S,p.R437C,p.R600C,p.W746S and p.W746 *) have been reported before.And five novel mutations (p.R168Q,p.R168P,p.E521V,p.R594H and c.827_845del) were found in this study.None of these novel mutations were found in 100 normal controls except for p.R168Q mutation in two normal controls.p.P361L and p.W746 * were detected in two unrelated GSD Ⅱ patients while other mutations were carried by only one patient.Conclusion In our study,we found several novel GAA mutations in Chinese patients with GSD Ⅱ.No hot spot mutation of GAA gene existed in our patient group.However,p.P266S,p.P361L and p.R437C might be associated with late-onset GSD Ⅱ.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第25期1981-1985,共5页 National Medical Journal of China
关键词 糖原累积病Ⅱ型 α-1 4葡萄糖苷酶 基因 突变 Glycogen storage disease type Ⅱ (GSD Ⅱ ) Acid α-glucosidase Gene Mutation
  • 相关文献

参考文献20

  • 1Kroos M, Pomponio RJ, van Vliet L, et al. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Murat, 2008, 29 :E13-E26.
  • 2Vedsted P, Mainz J, Olesen F. [ The significance of a reminder and physician's motivation for the response rate of a questionnaire survey in general practice]. Ugeskr Laeger, 2001, 163:5529- 5532.
  • 3Tsujino S, Huie M, Kanazawa N, et al. Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord, 2000, 10:599-603.
  • 4Fernandez-Hojas R, Huie ML, Navarro C, et al. Identification of six novel mutations in the acid alpha-glucosidase gene in threeSpanish patients with infantile onset glycogen storage disease type ( Pompe disease). Neuromuscul Disord, 2002, 12 : 159-166.
  • 5仇佳晶,魏珉,张为民,施惠平.幼年起病的2例晚发型糖原贮积症Ⅱ型/Pompe病临床和基因分析[J].中华儿科杂志,2007,45(10):760-764. 被引量:12
  • 6Malicdan MC, Nishino I. Autophagy in lysosomal myopathies. Brain Pathol, 2012, 22:82-88.
  • 7Winkel LP, Van den Hout JM, Kamphoven JH, et al. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Ann Neurol, 2004, 55:495-502.
  • 8Mellies U, Stehling F, Dohna-Schwake C, et al. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology, 2005, 64 : 1465-1467.
  • 9代英杰,陈琳,郭玉璞,关鸿志,刘智,任海涛,赵燕环,崔丽英.糖原累积病Ⅱ型20例临床及病理特点[J].中华神经科杂志,2011,44(2):91-95. 被引量:19
  • 10Labrousse P, Chien YH, Pomponio R J, et al. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol Genet Metab, 2010, 99:379-383.

二级参考文献35

  • 1陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 2Kishnani PS,Corzo D,Nicolino M,et al.Recombinant human acid[alpha] -glucosidase:major clinical benefits in infantile-onset Pompe disease.Neurology,2007,68:99-109.
  • 3van der Ploeg AT,Reuser AJ.Pompe's disease.Lancet,2008,372:1343-1353.
  • 4Kishnani PS,Steiner RD,Bali D,et al.Pompe disease diagnosis and management guideline.Gent Med,2006,8:267-288.
  • 5Katzin LW,Amato AA.Pompe disease:a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.J Clin Neuromuscul Dis,2008,9:421-431.
  • 6Hermans MM,van Leenen D,Kroos MA,et al.Twenty-two novel mutation in the lysosomal alpha-glucosidase gene (GAA)underscore the genotype-phenotype correlation in glycogen storage disease type Ⅱ.Hum Mutat,2004,23:47-56.
  • 7Hagemans ML,Winkel LP,Hop WC,et al.Disease severity in children and adults with Pompe disease related to age and disease duration.Neurology,2005,64:2139-2141.
  • 8Mellies U,Stehling F,Dohna-Schwake C,et al.Respiratory failure in Pompe disease:treatment with noninvasive ventilation.Neurology,2005,64:1465-1467.
  • 9Barnes D,Hughes RA,Spencer GT.Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis.J R Soc Med,1993,86:50.
  • 10Hagemans ML,Winkel LP,Van Doom PA,et al.Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.Brain,2005,128 Pt 3:671-677.

共引文献28

同被引文献97

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部